SCHEMBL25002037

SCHEMBL25002037

COc1cc(N2CCC3(CCOC3)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.60
▸ BTK Q06187 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25001676 0.97 EGFR (0.58) EGFR
SCHEMBL25001593 0.97 EGFR (0.60) EGFRBTK
SCHEMBL25001594 0.96 EGFR (0.62) EGFR
SCHEMBL25001799 0.93 EGFR (0.65) EGFR
SCHEMBL25001724 0.92 EGFR (0.68) EGFR
SCHEMBL22950947 0.92 EGFR (0.64) EGFRBTK
SCHEMBL25001973 0.92 EGFR (0.61) EGFR
SCHEMBL25001707 0.91 EGFR (0.63) EGFR
SCHEMBL25001670 0.91 EGFR (0.60) EGFR
SCHEMBL29877089 0.91 EGFR (0.60) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 — — EP disclosed
Send feedback